Alan R. Smyth
Prescribing practices for intravenous aminoglycosides in UK cystic fibrosis clinics: a questionnaire survey
Smyth, Alan R.; Campbell, Emma L.
Authors
Emma L. Campbell
Abstract
Background: Intravenous aminoglycoside antibiotics are widely used to treat pulmonary infection with Pseudomonas aeruginosa in individuals with cystic fibrosis (CF). Over the last decade evidence has accumulated showing that the choice of aminoglycoside and the dosing regimen may help reduce adverse effects such as nephrotoxicity.
Methods: We undertook an online survey to determine current practice in UK CF Centres.
Results: We received a response from 35/48 (73%) centres. A once daily regimen was used in 30/35 (86%) centres. Around one third had stopped using gentamicin in the last 10 years. In most cases respondents reported changing practice in response to new evidence or evidence based guidelines. Obstacles to introducing evidence based practice were identified both at the level of the CF Centre and the hospital trust.
Conclusions: A once daily aminoglycoside regimen is now used in the majority of UK CF Centres. Tobramycin is first line and many centres have stopped using gentamicin. Obstacles to evidence based practice remain in a minority of centres.
Citation
Smyth, A. R., & Campbell, E. L. (2014). Prescribing practices for intravenous aminoglycosides in UK cystic fibrosis clinics: a questionnaire survey. Journal of Cystic Fibrosis, 13(4), https://doi.org/10.1016/j.jcf.2013.11.007
Journal Article Type | Article |
---|---|
Publication Date | Jul 1, 2014 |
Deposit Date | Feb 15, 2016 |
Publicly Available Date | Feb 15, 2016 |
Journal | Journal of Cystic Fibrosis |
Print ISSN | 1569-1993 |
Electronic ISSN | 1873-5010 |
Publisher | Elsevier |
Peer Reviewed | Peer Reviewed |
Volume | 13 |
Issue | 4 |
DOI | https://doi.org/10.1016/j.jcf.2013.11.007 |
Keywords | Cystic fibrosis; aminoglycosides; nephrotoxicity; once daily dosing; obstacles to evidence based practice |
Public URL | https://nottingham-repository.worktribe.com/output/995526 |
Publisher URL | http://www.sciencedirect.com/science/article/pii/S1569199313001975 |
Files
Smyth JCF 2013 Table 1 .pdf
(42 Kb)
PDF
Copyright Statement
Copyright information regarding this work can be found at the following address: http://creativecommons.org/licenses/by-nc-nd/4.0
Smyth JCF 2013 AG survey v4 .pdf
(137 Kb)
PDF
Copyright Statement
Copyright information regarding this work can be found at the following address: http://creativecommons.org/licenses/by-nc-nd/4.0
You might also like
Time for a proper career pathway for clinical trial managers?
(2023)
Journal Article
EPCT-03. Working together to accelerate the preclinical to clinical translation of drug delivery systems for children’s brain tumours
(2022)
Presentation / Conference Contribution
Downloadable Citations
About Repository@Nottingham
Administrator e-mail: discovery-access-systems@nottingham.ac.uk
This application uses the following open-source libraries:
SheetJS Community Edition
Apache License Version 2.0 (http://www.apache.org/licenses/)
PDF.js
Apache License Version 2.0 (http://www.apache.org/licenses/)
Font Awesome
SIL OFL 1.1 (http://scripts.sil.org/OFL)
MIT License (http://opensource.org/licenses/mit-license.html)
CC BY 3.0 ( http://creativecommons.org/licenses/by/3.0/)
Powered by Worktribe © 2024
Advanced Search